Innealta Capital’s Evolent Health EVH Stock Holding History

Innealta Capital’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-37	Closed	-$707	–	658
2024 Q2	$707	Buy	+37	New	+$945	﹤0.01%	1396

Other funds holding EVH

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Innealta Capital's EVH Position: Q3 2024 in Review

Innealta Capital sold out of Evolent Health (EVH) in Q3 2024, closing a stake of 37 shares — an estimated $707 sold.

Innealta Capital first reported a position in EVH in Q2 2024 and held it in 1 quarter. The position peaked at $707 in Q2 2024. 262 funds tracked by Wall St. Rank hold EVH as of Q3 2024.

Innealta Capital reported no remaining Evolent Health position as of Q3 2024 after selling out during the quarter.
Innealta Capital sold 37 Evolent Health shares in Q3 2024, an estimated $707.
Innealta Capital first reported a position in Evolent Health in Q2 2024 and held it in 1 quarter.
Innealta Capital's Evolent Health position peaked at $707 in Q2 2024.
262 funds tracked by Wall St. Rank held Evolent Health as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.